Industry News

- Read more about Daiichi Sankyo Espha introduce 7 new generic drugs with 4 new active ingredients
Daiichi Sankyo Company, Limited's generics subsidiary, Daiichi Sankyo Espha, will launch seven new generic drugs with four new active ingredients. The products: Naftopidil OD tablets 25mg, 50mg, 75mg “DSEP” (Flivas OD tablets 25mg, 50mg, 75mg) for the treatment for urination disorder due to enlargement of prostate; Metformin hydrochloride tablets 250mgMT, 500mgMT “DSEP” (Metgluco tablets 250mg, 500mg) for biguanide-type oral hypoglycemic agent; Letrozole tablets 2.5mg “DSEP” (Femara tablets 2.5mg) Aromatase inhibitor/postmenopausal breast cancer treatment; Oxaliplatin IV infusion solution 200mg “DSEP” (Elplat IV infusion solution 200mg) anti-malignant tumour agent.
- Read more about OTC hair growth supplement launched in India by Dr. Reddy's Lab
Dr. Reddy’s today announced the launch of HAiROOTZ™, the first hair growth supplement to be marketed in India as over-the-counter (OTC) by the company. HAiROOTZ™ comes from the same branch of business that markets MINTOP^TM, the No. 1 dermatologist recommended brand in the country.
- Read more about Teva Pharma's Biologics License Application for reslizumab accepts by USFDA
The US Food and Drug Administration (FDA) has accepted for review Teva Pharmaceutical's Biologics License Application (BLA) for reslizumab for the treatment of inadequately controlled asthma in adult and adolescent patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based regimen.
- Read more about Glenmark got US FDA approval for levonorgestrel and ethinyl estradiol tablets
Glenmark Pharmaceuticals, USA has been granted final approval by the United States Food & Drug Administration (FDA) for the extended-cycle oral contraceptive, levonorgestrel/ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, the AB-rated generic version of Seasonale by Teva Women’s Health.

[adsense:336x280:8701650588]
- Read more about WorldStar 2015 Award win by ACG Pharmapack’s anti-fog film
ACG Pharmapack – a member of ACG Worldwide – is proud to have received the prestigious WorldStar 2015 Award from World Packaging Organization for its innovative. ACG Pharmapack, a member of ACG Worldwide, has received the prestigious WorldStar 2015 Award from World Packaging Organization for its innovative product, NoMist. An anti-fog packaging film, NoMist bagged the Award in the pharma & medical category, after having won the IndiaStar (organized by the Indian Institute of Packaging) and AsiaStar (organized by the Asian Packaging Federation) awards. The award ceremony and cocktail reception was held in Milan, Italy.
- Read more about Waters launch Acquity Arc System: As a bridge between HPLC and UPLC methods
Waters has introduced the Acquity Arc System, a quaternary liquid chromatograph that gives analytical laboratories running established LC methods a clear choice for replicating or improving their separations performance. The company intends to begin shipping the Acquity Arc system to customers by this month end.
- Read more about Carna Biosciences & Janssen collaborates to develop small molecule protein kinase inhibitor
Carna Biosciences, a leading provider of drug discovery supporting products and services, collaborate with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical companies of Johnson & Johnson, to develop and commercialize small molecule protein kinase inhibitor programmes.
- Read more about US FDA approves Novartis' Promacta to treat chronic immune thrombocytopenia in childrens
The US Food and Drug Administration (FDA) has approved Novartis' Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.
- Read more about Philips India collaborate with IBA to enhance access to proton therapy in India
Philips India and Ion Beam Applications S.A. (IBA), a global leader in proton therapy for the treatment of cancer, signed an exclusive agreement to enhance access to proton therapy in India. The collaboration also enables both organizations to mutually leverage technologies and solutions. Two companies have already signed multiple country-specific collaboration agreements, each optimized for the local market needs.The alliance combines Philips’ expertise and innovative imaging techniques for strengths in proton therapy.
- Read more about Jubilant Life Sciences raise price of Niacinamide by 10%
Jubilant Life Sciences, one of the leading players in nutrition market and the largest manufacturers of vitamin B3 (Niacin and Niacinamide) in the world, announced a price increase of 10 per cent for Niacinamide, with immediate effect, for non-contract customers and wherever existing contracts permit. Niacin and niacinamide are forms of vitamin B3 and used in various pharmaceutical products.